Skip to content Skip to footer

International Cannabis Weekly: 170

October 23, 2020

Highlights

Share this story
Highlights

 

NEW REPORT EXAMINES THE IMPACT OF CANNABIS ON PHARMACEUTICAL INDUSTRY

The rapid growth of cannabis-based medicines is becoming a significant disruptor of the global pharmaceutical industry, but the point of entry has been complicated by the historic scheduling of cannabis as a schedule 1 narcotic.

However, pharmaceutical cannabis products such as Epidyolex, Sativex and Dronabinol have become serious alternatives to traditional pharmaceuticals and are beginning to shift how the pharma industry approaches cannabis.

The Pharmaceutical Cannabis Report is now available both in digital and print versions for purchase.

 

ACCESS NOW

HIGHLIGHTS

Highlights

Share this story
Europe

 

Highlights

Share this story
CANNABIS EUROPA RETURNS TO PROHIBITION PARTNERS LIVE

 

Cannabis Europa makes a timely return to Prohibition Partners LIVE next month.

Between 17-20 November, European business leaders & policymakers will converge virtually to help shape the future of cannabis.

Early Bird Tickets (£115 / €127) includes four-day event access.

 

LEARN MORE

Highlights

Share this story
USA

 

Highlights

Share this story
CANXCHANGE

Highlights

Share this story
Canada

 

Highlights

Share this story
Latam & Caribbean

 

Highlights

Share this story
APAC

 

Highlights

Share this story
Africa & Middle East

 

Latest Issues

254

253

252

251

250

249

Insights

On the global cannabis industry

International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 70,000+ subscribers.